Lifeline Biotechnologies Inc (LLBO)

[E-7-2]

I have always thought the biggest challenge for getting this to market was managing the tremendous amount of data with zero errors. You cannot make a mistake and send someone an incorrect diagnosis. If this company can manage the data then that’s a huge issue resolved. Like others have said the major players who have invested in Carcadia gives us hope for implementation in the future. When is anyone’s guess. But, worth a bet. It’s only .0014. Bought another 100,000 shares today. If you can’t afford $140.00 bucks then you shouldn’t be allowed on this board.